RECENT FUNDING ROUNDS


Country Profile Funding round Value Date
Parse Biosciences Provider of single-cell sequencing solutions. Series C USD 50,000,000
Parse Biosciences Provider of single-cell sequencing solutions. Debt
Vivodyne Inc Philadelphia-based biotech that tests its drug candidates on lab-grown human organs. Seed USD 38,000,000
Osium AI French AI startup focused on material sciences R&D. Seed USD 2,600,000
Parse Biosciences Provider of single-cell sequencing solutions. N/A USD 7,000,000
Abalone Bio Antibody drug discovery. Seed
Science Exchange Inc Online marketplace for scientific collaboration where researchers can order experiments from the world's best laboratories. N/A USD 20,000,000
Quell Therapeutics Ltd Developer of engineered T regulatory cell therapies. Series A GBP 35,000,000
Cambridge Cancer Genomics Ltd CCG.ai empowers clinicians to make personalised treatment strategies. Seed
Ginkgo Bioworks Inc DNA design company. Series D USD 275,000,000
Armo BioSciences Inc Late-stage immuno-oncology company. Series C-1 USD 67,000,000
EpimAb Biotherapeutics Biopharmaceutical company focused on bispecific antibodies. Series A USD 25,000,000
Oxford Nanopore Technologies Ltd Developing the GridION system, a new generation of technology that uses nanopores - very small holes created in electrically resistant membranes. Venture GBP 100,000,000
Novogene Technology Co Ltd Provider of genomic services. Series B CNY 515,000,000
Tetra Discovery Partners Inc Biotechnology company developing treatments for Alzheimer's disease and other brain disorders. Series A USD 5,000,000
Science 37 Inc Provider of technology enabled clinical research solutions. Series B USD 31,000,000
ReadCoor Series A USD 23,000,000
Mitra Biotech Pvt Ltd Developer of personalized cancer treatments. Series B USD 27,400,000
Medivation Inc Acquisition USD 14,000,000,000
Avelas Biosciences Inc Provider of advance, new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons. Series C USD 20,000,000

BEST FUNDED STARTUPS


A biotechnology company, develops medicines to treat cancer and fibrotic diseases

Singapore-based cancer therapeutics company which, focuses on the discovery, research, and clinical development of small molecule drugs.

Philadelphia-based biotech that tests its drug candidates on lab-grown human organs.

Provider of genomic services.

Web-based provider of scientifically-tested brain training games

Late-stage immuno-oncology company.

Bopharmaceutical company, focuses on the identification, development, commercialization of therapeutic compounds for osteo-renal diseases treatment.

Biopharmaceutical company.

Provider of single-cell sequencing solutions.

Biotechnology company providing preconception and prenatal genetic testing services.

Provider of advance, new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons.

Online marketplace for scientific collaboration where researchers can order experiments from the world's best laboratories.

Provider of technology enabled clinical research solutions.

Developer of genomic testing systems.